Related Experiment Video
Updated: Oct 10, 2025
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
Does GD2 synthase (GD2S) detect cancer stem cells in blood samples of breast carcinomas?
Maryam Mansoori1,2, Isa Abdi Rad3, Alireza Mirzaei4
1Iran University of Medical Sciences, Oncopathology Research Center, Tehran, Iran.
Introduction:
Cancer stem cells (CSCs) are a theorized subset of cells within the tumor that is thought to drive disease recurrence and metastatic spread. The aim of this study is to investigate mRNA and protein levels of ganglioside GD2 synthase (GD2S), in breast cancer (BC) patients.
Methods:
65 PBMCs of preoperative BC patients without chemotherapy were compared to PBMCs after chemotherapy and controls.
Results:
GD2S were significantly higher in BC patients after chemotherapy compared to pre-chemotherapy at both mRNA and protein. GD2S was higher in pre-chemotherapy blood samples compared to control samples.
Conclusions:
Higher expression of GD2S in BC samples compared to healthy control indicates the potential utility of GD2S as a marker of malignancy.
More Related Videos
07:03Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
